Skip to main content
OpenTrials

Clinical trial condition

Spinal Cord Diseases

Explore clinical trials studying Spinal Cord Diseases. Study availability and eligibility vary by location and protocol.

2,929 public trials 591 recruiting studies
Refine in advanced search Browse all conditions

Spinal Cord Diseases trial results

Active, Not Recruiting

Monitoring to the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®

NCT04159987

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
Locations
  • CHU de Lyon Lyon, Auvergne-Rhône-Alpes, France
  • CHRU de Lille Lille, Hauts-de-France, France
  • CHU de Montpellier Montpellier, Occitanie, France
  • CHU de Toulouse Toulouse, Occitanie, France
View Trial Details
Active, Not Recruiting

A Clinical Study Evaluating the Safety and Efficacy of SKG0201 Injection in Patients With Spinal Muscular Atrophy Type 1

NCT06191354

Conditions
Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more
Locations
  • West China Sencond Hospital, Sichuan University / West China women's and children's Hospital Chengdu, Sichuan, China
  • Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine Shanghai, China
  • National Children's Medical Center, Children's Hospital of Fudan University Shanghai, China
View Trial Details
Active, Not Recruiting

A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia

NCT05515536

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +11 more
Locations
  • UCLA Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)

NCT06100276

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California Irvine Irvine, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
View Trial Details

Related conditions